Daniel M. Rubin, ND

The Clinical Utility of Intravenous Ascorbate as an Antitumor Chemotherapeutic Agent and Immune Modulator

AAX09-190

AANP 2000 Convention ~ Bellevue, Washington

  • Sale
  • Regular price $9.95


High-dose intravenous ascorbate is a potent antitumor agent when used appropriately. This talk covers the protocol for its use in cancer and steps to follow to ensure safety during administration. Dr. Rubin discusses laboratory tests necessary to determine appropriate dosing schedules. All material is supported by scientific (laboratory) and clinical data. Cases are presented at the end of the session.